Additional Treatment with Low-Molecular-Weight Heparin Provides a Better Patient Outcome for Neonatal Pulmonary Hemorrhage with Unfractionated Heparin Treatment

<div>The PaCO<sub>2</sub> and PaO<sub>2</sub> of each patient in the observation and control group before, 6 h, and 24 h after unfractionated heparin treatment with or without additional low-molecular-weight heparin treatment.</div>

Journal of Nanomaterials

tab1

Table 1

Table 1: Additional Treatment with Low-Molecular-Weight Heparin Provides a Better Patient Outcome for Neonatal Pulmonary Hemorrhage with Unfractionated Heparin Treatment 

Table 1 | Additional Treatment with Low-Molecular-Weight Heparin Provides a Better Patient Outcome for Neonatal Pulmonary Hemorrhage with Unfractionated Heparin Treatment 